Compare

Oscar Health/$OSCR

1D1W1M3M6MYTD1Y5YMAX

About Oscar Health

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Ticker
$OSCR
Sector
Finance
Primary listing
NYSE
Employees
2,305

Oscar Health Metrics

BasicAdvanced
$10B
17.71
$1.91
2.39
-

What the Analysts think about Oscar Health

Analyst ratings (Buy, Hold, Sell) for Oscar Health stock.
Analyst projections of the future price of Oscar Health stock.

Bulls say / Bears say

Oscar reported $1.09bn of operating earnings for the first half, versus $66.6m a year earlier, and raised its 2026 operating-earnings outlook to $500m–$700m from $250m–$450m. That sharp improvement gives the turnaround more evidence than a growth story alone. (Oscar Health)
Second-quarter revenue rose 70% year on year to $4.88bn, while membership reached 2.96m, up 46%. Growing scale could spread fixed costs across a larger book and support further margin gains if pricing holds. (Oscar Health, Last10K)
Employer use of CHOICE and ICHRA arrangements is widening: a cited HRA Council study found participating employers more than doubled to over 12,700 in 2026, with adoption among firms with 1,000-plus workers up 178%. This could give Oscar another growth channel beyond conventional individual enrolment. (Oscar Health)
Oscar expects 250,000–300,000 marketplace members to be retroactively disenrolled under CMS eligibility reviews, and says second-half churn could be roughly twice its earlier expectation. This threatens enrolment momentum and makes revenue harder to forecast. (Distilinfo)
The ACA market is under affordability pressure: Reuters reported 2026 sign-ups fell 5%, and cited estimates that effectuated enrolment could fall 17%–26% by March as enhanced subsidies expired and premiums rose. A smaller, potentially less healthy pool could weigh on Oscar’s growth and claims economics. (Reuters)
Oscar’s second-quarter results included a $160m favourable true-up to 2025 risk adjustment, while it carried a $4.85bn net risk-adjustment payable at June-end. These large, delayed transfers leave reported margins sensitive to estimates and later CMS reconciliations. (The Motley Fool, Actuary.info)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2026.

Oscar Health Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Oscar Health Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Oscar Health

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.